SR One News

BY CATEGORY: ALL / NOTABLE / CLINICAL IMPACT / NEW INVESTMENTS / FINANCING AND PARTNERSHIPS / PEOPLE

BY YEAR: 2023 / 2022 / 2021 / 2020

PsiOxus Therapeutics to present positive biomarker data at ESMO 2021

Frances Benson 9/15/21 Frances Benson 9/15/21

PsiOxus Therapeutics to present positive biomarker data at ESMO 2021

Read More

ADARx Pharmaceuticals raises $75M in Series B

Frances Benson 9/8/21 Frances Benson 9/8/21

ADARx Pharmaceuticals raises $75M in Series B

Read More

ARS Pharmaceuticals raises $55M in Series D

Frances Benson 8/31/21 Frances Benson 8/31/21

ARS Pharmaceuticals raises $55M in Series D

Read More

Frances Benson 8/25/21 Frances Benson 8/25/21

eFFECTOR Therapeutics debuts as public company

Read More

Turning Point Therapeutics initiates Ph1b/2 combination study

Frances Benson 8/16/21 Frances Benson 8/16/21

Turning Point Therapeutics initiates Ph1b/2 combination study

Read More

BioTheryX appoints three new members to its Board of Directors

Frances Benson 8/6/21 Frances Benson 8/6/21

BioTheryX appoints three new members to its Board of Directors

Read More

Frances Benson 8/4/21 Frances Benson 8/4/21

eFFECTOR Therapeutics initiates Zotatifin Ph2a in breast and lung cancers

Read More

Frances Benson 7/22/21 Frances Benson 7/22/21

eFFECTOR Therapeutics doses first COVID- 19 patient in Zotatifin Ph1b trial

Read More

Bicycle Therapeutics enters exclusive license and collaboration agreement with Ionis

Frances Benson 7/13/21 Frances Benson 7/13/21

Bicycle Therapeutics enters exclusive license and collaboration agreement with Ionis

Read More

Nimbus Therapeutics raises $105M from top investors

Frances Benson 7/13/21 Frances Benson 7/13/21

Nimbus Therapeutics raises $105M from top investors

Read More

Morphic Therapeutic new data from positive Ph1 study of MORF-057

Frances Benson 7/9/21 Frances Benson 7/9/21

Morphic Therapeutic new data from positive Ph1 study of MORF-057

Read More

Turning Point Therapeutics receives orphan drug designation for TPX-0022 in gastric cancer

Frances Benson 6/17/21 Frances Benson 6/17/21

Turning Point Therapeutics receives orphan drug designation for TPX-0022 in gastric cancer

Read More

CRISPR Therapeutics and Capsida Biotherapeutics announce strategic collaboration

Frances Benson 6/15/21 Frances Benson 6/15/21

CRISPR Therapeutics and Capsida Biotherapeutics announce strategic collaboration

Read More

Frances Benson 6/9/21 Frances Benson 6/9/21

eFFECTOR Therapeutics doses first patient in Ph2b kickstart clinical trial

Read More

Frances Benson 5/27/21 Frances Benson 5/27/21

eFFECTOR Therapeutics and Locust Walk Acquisition Corp Annouce Merger

Read More

Pulmocide raises $92M in Series C

Frances Benson 5/27/21 Frances Benson 5/27/21

Pulmocide raises $92M in Series C

Read More

Tranquis Therapeutics appoints Frederic Godderis as COO and Jonas Hannestad as CMO

Frances Benson 5/26/21 Frances Benson 5/26/21

Tranquis Therapeutics appoints Frederic Godderis as COO and Jonas Hannestad as CMO

Read More

Turning Point Therapeutics appoints Mark Alles to chair its Board of Directors

Frances Benson 5/25/21 Frances Benson 5/25/21

Turning Point Therapeutics appoints Mark Alles to chair its Board of Directors

Read More

BioTheryX raises $92M in Series E

Frances Benson 5/20/21 Frances Benson 5/20/21

BioTheryX raises $92M in Series E

Read More

Fore Biotherapeutics strengthens leadership team

Frances Benson 5/19/21 Frances Benson 5/19/21

Fore Biotherapeutics strengthens leadership team

Read More